496 results on '"Smoldering Multiple Myeloma"'
Search Results
2. A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
3. Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
4. DARA RVD For High Risk SMM (PRISM)
5. A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma
6. Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
7. Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
8. Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
9. Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma (ERASMM)
10. A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma (LINKER-MGUS1)
11. A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
12. Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
13. Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
14. A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
15. Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
16. Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)
17. Promoting Diagnosis and Management of AL in Italy (ProDigALIty) (ProDigALIty)
18. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
19. Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
20. Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (TRANSFORMM)
21. A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
22. Screening for AL Amyloidosis in Smoldering Multiple Myeloma
23. Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
24. A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
25. A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)
26. Registry for Adults With Plasma Cell Disorders (PCD's)
27. A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma
28. Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. (CARRISMM)
29. Teclistamab or Talquetamab in Combination With Daratumumab for High-Risk Smoldering Myeloma (REVIVE Study) (REVIVE)
30. Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma
31. Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
32. Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
33. Denosumab for Smoldering Multiple Myeloma
34. European Myeloma Network (EMN) Sample Project (EMN36)
35. Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial (SPOTLIGHT)
36. Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions.
37. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT)
38. Screening to Improve Survival in AL Amyloidosis
39. The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
40. Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM (HO147SMM)
41. Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
42. Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
43. Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
44. Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
45. Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
46. Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
47. Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
48. Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
49. Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
50. Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.